10-(4-Phenylpiperazine-1-carbonyl)acridin-9(10H)-ones and related compounds: Synthesis, antiproliferative activity and inhibition of tubulin polymerization.

Bioorganic & Medicinal Chemistry Letters
Jana WaltemateHelge Prinz

Abstract

As part of our continuing search for potent inhibitors of tubulin polymerization, two novel series of 42 10-(4-phenylpiperazine-1-carbonyl)acridin-9(10H)-ones and N-benzoylated acridones were synthesized on the basis of a retrosynthetic approach. All newly synthesized compounds were tested for antiproliferative activity and interaction with tubulin. Several analogs potently inhibited tumor cell growth. Among the compounds tested, 10-(4-(3-methoxyphenyl)piperazine-1-carbonyl)acridin-9(10H)-one (17c) exhibited excellent growth inhibitory effects on 93 tumor cell lines, with an average GI50 value of 5.4 nM. We were able to show that the strong cytotoxic effects are caused by disruption of tubulin polymerization, as supported by the EBI (N,N'-Ethylenebis(iodoacetamide)) assay and the fact that the most potent inhibitors of cancer cell growth turned out to be the most efficacious tubulin polymerization inhibitors. Potencies were nearly comparable or superior to those of the antimitotic reference compounds. Closely related to this, the most active analogs inhibited cell cycling at the G2/M phase at concentrations down to 30 nM and induced apoptosis in K562 leukemia cells. We believe that our work not only proves the excellent suitabi...Continue Reading

References

Jan 1, 1977·Journal of the Chemical Society. Perkin Transactions 1·M J de Oliveira BaptistaN A Usher
Jul 17, 1998·Medicinal Research Reviews·A JordanA T McGown
May 11, 2000·Organic Letters·J Yin, S L Buchwald
Aug 31, 2000·Annual Review of Biochemistry·E Nogales
Mar 6, 2003·Journal of the American Chemical Society·Jacopo ZanonStephen L Buchwald
Dec 10, 2003·Oncogene·Kapil N Bhalla
Apr 2, 2004·Nature Reviews. Cancer·Mary Ann Jordan, Leslie Wilson
May 23, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Eddy PasquierDiane Braguer
Apr 5, 2007·Nature Protocols·Vanicha Vichai, Kanyawim Kirtikara
Oct 10, 2007·Apoptosis : an International Journal on Programmed Cell Death·Anna SkwarskaJerzy Konopa
Apr 12, 2008·Cell Death and Differentiation·H VakifahmetogluB Zhivotovsky
Apr 10, 2009·Nature·Jane X KellyMichael K Riscoe
Jul 15, 2009·Anti-cancer Agents in Medicinal Chemistry·Q C NguyenF Tillequin
Jul 25, 2009·Journal of Cell Science·Karen E Gascoigne, Stephen S Taylor
Feb 12, 2010·Nature Reviews. Cancer·Maria Kavallaris
Mar 20, 2010·Nature Reviews. Cancer·Sreenath V SharmaJeff Settleman
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Jan 1, 2010·Biological Procedures Online·Sébastien FortinRené C-Gaudreault
May 24, 2011·Pharmacological Reports : PR·Grzegorz CholewińskiAleksander M Kołodziejczyk
Nov 17, 2011·Nature Reviews. Molecular Cell Biology·Carsten Janke, Jeannette Chloë Bulinski
Jun 28, 2012·Journal of Cell Science·Sylvain Meunier, Isabelle Vernos
Jul 21, 2012·Pharmaceutical Research·Yan LuDuane D Miller
Oct 19, 2012·Journal of Medicinal Chemistry·Victor Hernandez-OlmosChrista E Müller
May 20, 2014·Chembiochem : a European Journal of Chemical Biology·Xiangqian LiZhichao Zhang
Aug 13, 2014·Proceedings of the National Academy of Sciences of the United States of America·Andrea E ProtaMichel O Steinmetz
Dec 30, 2014·Acta Crystallographica. Section A, Foundations and Advances·George M Sheldrick
Jan 9, 2015·Acta Crystallographica. Section C, Structural Chemistry·George M Sheldrick
Jan 27, 2015·Current Medicinal Chemistry·Ya-Ting JiZhao-Peng Liu
Jan 16, 2016·Oncotarget·Olivia SlossStephen Taylor
Feb 24, 2016·Anti-cancer Agents in Medicinal Chemistry·Xiaoxin WuWei Li
Oct 19, 2016·British Journal of Clinical Pharmacology·Darcy Bates, Alan Eastman
Aug 2, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hao ChenWei Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis